Combined symptoms of diabetes distress, depression, and anxiety and their association with glycemic control in primary care patients with type 2 diabetes in Egypt.

IF 1.3 Q4 ENDOCRINOLOGY & METABOLISM
Diabetology International Pub Date : 2025-01-27 eCollection Date: 2025-04-01 DOI:10.1007/s13340-025-00793-2
Hazem A Sayed Ahmed, Samar F Mohamed, Anwar I Joudeh, Sally Fawzy Elotla, Mona Mostafa, Jaffer Shah, Ahmed Mahmoud Fouad, Samy Abdelrazek Abdelazim
{"title":"Combined symptoms of diabetes distress, depression, and anxiety and their association with glycemic control in primary care patients with type 2 diabetes in Egypt.","authors":"Hazem A Sayed Ahmed, Samar F Mohamed, Anwar I Joudeh, Sally Fawzy Elotla, Mona Mostafa, Jaffer Shah, Ahmed Mahmoud Fouad, Samy Abdelrazek Abdelazim","doi":"10.1007/s13340-025-00793-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Existing studies mostly focus on the separate impacts of diabetes distress, depression, and anxiety on glycemic control, leaving a gap in understanding their combined influence within primary care settings. This study aims to explore this interaction among patients with type 2 diabetes mellitus (T2DM) in Egyptian primary healthcare.</p><p><strong>Methods: </strong>The study was conducted in rural primary healthcare settings in Egypt from September 2020 to June 2021, included 354 patients with T2DM. Sociodemographic, lifestyle, and clinical characteristics were assessed through patient interviews. Diabetes distress was measured using the 5-item Problem Areas in Diabetes Scale (PAID-5 scale), and symptoms of depression and anxiety were evaluated using the Patient Health Questionnaire 9 (PHQ-9) and the Generalized Anxiety Disorder 7 Scale (GAD-7), respectively. Glycated hemoglobin (HbA1c) measurements indicated glycemic control.</p><p><strong>Results: </strong>Participants experienced varying mental health symptoms: 24.9% had one symptom, 8.2% had two, and 4.5% had all three (diabetes distress, depression, and anxiety symptoms). In multiple linear regression, not working status (β = -0.203, p = 0.015), dyslipidemia (β = 0.258, p = 0.021), increased BMI (β = 0.022, p < 0.001), and more mental health symptoms (β = 0.267, p < 0.001) predicted higher HbA1c levels. Ordinal regression found that higher educational levels (OR = 2.385, p = 0.021), sufficient income (OR = 2.360, p = 0.007), and higher HbA1c (OR = 3.103, p < 0.001) predicted more mental health symptoms.</p><p><strong>Conclusion: </strong>Mental health symptoms were common, and there were reciprocal associations between elevated HbA1c levels and increased mental health symptoms.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13340-025-00793-2.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"16 2","pages":"326-338"},"PeriodicalIF":1.3000,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11954776/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetology International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13340-025-00793-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Existing studies mostly focus on the separate impacts of diabetes distress, depression, and anxiety on glycemic control, leaving a gap in understanding their combined influence within primary care settings. This study aims to explore this interaction among patients with type 2 diabetes mellitus (T2DM) in Egyptian primary healthcare.

Methods: The study was conducted in rural primary healthcare settings in Egypt from September 2020 to June 2021, included 354 patients with T2DM. Sociodemographic, lifestyle, and clinical characteristics were assessed through patient interviews. Diabetes distress was measured using the 5-item Problem Areas in Diabetes Scale (PAID-5 scale), and symptoms of depression and anxiety were evaluated using the Patient Health Questionnaire 9 (PHQ-9) and the Generalized Anxiety Disorder 7 Scale (GAD-7), respectively. Glycated hemoglobin (HbA1c) measurements indicated glycemic control.

Results: Participants experienced varying mental health symptoms: 24.9% had one symptom, 8.2% had two, and 4.5% had all three (diabetes distress, depression, and anxiety symptoms). In multiple linear regression, not working status (β = -0.203, p = 0.015), dyslipidemia (β = 0.258, p = 0.021), increased BMI (β = 0.022, p < 0.001), and more mental health symptoms (β = 0.267, p < 0.001) predicted higher HbA1c levels. Ordinal regression found that higher educational levels (OR = 2.385, p = 0.021), sufficient income (OR = 2.360, p = 0.007), and higher HbA1c (OR = 3.103, p < 0.001) predicted more mental health symptoms.

Conclusion: Mental health symptoms were common, and there were reciprocal associations between elevated HbA1c levels and increased mental health symptoms.

Supplementary information: The online version contains supplementary material available at 10.1007/s13340-025-00793-2.

导言:现有的研究大多集中在糖尿病困扰、抑郁和焦虑对血糖控制的单独影响上,在了解它们在初级医疗机构中的综合影响方面存在空白。本研究旨在探讨埃及初级医疗机构中 2 型糖尿病(T2DM)患者之间的这种相互作用:研究于 2020 年 9 月至 2021 年 6 月在埃及农村初级医疗机构进行,共纳入 354 名 T2DM 患者。通过对患者进行访谈,评估其社会人口学、生活方式和临床特征。糖尿病困扰采用 5 项糖尿病问题领域量表(PAID-5 量表)进行测量,抑郁和焦虑症状分别采用患者健康问卷 9(PHQ-9)和广泛性焦虑症 7 级量表(GAD-7)进行评估。糖化血红蛋白(HbA1c)测量结果显示血糖控制情况:结果:参与者的心理健康症状各不相同:24.9%的人有一种症状,8.2%的人有两种症状,4.5%的人有三种症状(糖尿病困扰、抑郁和焦虑症状)。在多元线性回归中,非工作状态(β = -0.203,p = 0.015)、血脂异常(β = 0.258,p = 0.021)、体重指数增加(β = 0.022,p 结论:糖尿病患者的心理健康症状普遍存在,并且在糖尿病患者中的比例很高:心理健康症状很常见,HbA1c 水平升高与心理健康症状增加之间存在相互关联:在线版本包含补充材料,可在 10.1007/s13340-025-00793-2上查阅。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetology International
Diabetology International ENDOCRINOLOGY & METABOLISM-
CiteScore
3.90
自引率
4.50%
发文量
42
期刊介绍: Diabetology International, the official journal of the Japan Diabetes Society, publishes original research articles about experimental research and clinical studies in diabetes and related areas. The journal also presents editorials, reviews, commentaries, reports of expert committees, and case reports on any aspect of diabetes. Diabetology International welcomes submissions from researchers, clinicians, and health professionals throughout the world who are interested in research, treatment, and care of patients with diabetes. All manuscripts are peer-reviewed to assure that high-quality information in the field of diabetes is made available to readers. Manuscripts are reviewed with due respect for the author''s confidentiality. At the same time, reviewers also have rights to confidentiality, which are respected by the editors. The journal follows a single-blind review procedure, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. Single-blind peer review is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信